etoposide has been researched along with Central Nervous System Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, B; Bentz, M; Borchmann, P; Dreyling, M; Frontzek, F; Glass, B; Haenel, M; Held, G; Horn, H; Kroschinsky, FP; Lenz, G; Loeffler, M; Metzner, B; Nickelsen, M; Ott, G; Rosenwald, A; Schmitz, N; Staiger, AM; Truemper, L; Viardot, A; Ziepert, M | 1 |
| Aricò, M; Egeler, RM; Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Trottestam, H; Webb, D | 1 |
| Crowell, EB; Higa, GM; Wise, TC | 1 |
| Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T | 1 |
| Bishop, JF; Bradstock, K; Cobcroft, R; Enno, A; Fox, R; Garson, OM; Gillett, A; Herrmann, R; Joshua, D; Juneja, S; Lowenthal, RM; Matthews, JP; Page, F; Szer, J; Van Der Weyden, M; Wolf, MM; Young, GA | 1 |
| Howells, DW; Hyland, K; Levinsky, RJ; Smith, I; Strobel, S | 1 |
2 trial(s) available for etoposide and Central Nervous System Diseases
| Article | Year |
|---|---|
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Intention to Treat Analysis; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Progression-Free Survival; Rituximab; Safety; Topoisomerase II Inhibitors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2021 |
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 1996 |
4 other study(ies) available for etoposide and Central Nervous System Diseases
| Article | Year |
|---|---|
Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Dexamethasone; Etoposide; Female; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Proportional Hazards Models; Seizures; Stem Cell Transplantation; Survival Rate; Tomography, X-Ray Computed | 2008 |
Severe, disabling neurologic toxicity following cisplatin retreatment.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cerebrovascular Disorders; Cisplatin; Cognition Disorders; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms | 1995 |
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia | 1994 |
Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management.
Topics: Biopterins; Central Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Macrophage Activation; Methotrexate; Neopterin; Prednisolone; Virus Diseases | 1990 |